Keeping up to date on recommended vaccinations helps reduce the risk of severe illness, keeps communities healthy and reduces the burden on our health care system. Community-driven initiatives across Canada… Read More
PADCEV plus pembrolizumab approved based on EV-302 trial KIRKLAND, QC – Pfizer Canada ULC announced that Health Canada has approved PADCEV® (enfortumab vedotin) an antibody-drug conjugate (ADC) in combination with… Read More
Approval is based on the Phase 3 KEYNOTE-A39 trial KIRKLAND, QC – Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that Health Canada has granted… Read More
DehydraTECH-liraglutide is outperforming DehydraTECH-semaglutide Select DehydraTECH-CBD formulations appear to continue to outperform DehydraTECH-semaglutide KELOWNA, BC – Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms… Read More
WELL Health subsidiary, OceanMD, and HEALWELL subsidiary, Intrahealth, announce a partnership to integrate OceanMD’s leading eReferral system across Intrahealth’s global network to enhance digital interoperability, streamline healthcare processes, and improve… Read More
